Vascular Biogenics Ltd reports results for the quarter ended in June - Earnings Summary

Notable Labs

16/08/2021 13:03

* Vascular Biogenics Ltd  VBLT.OQ  reported a quarterly adjusted
loss of 12 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 11 cents per share.
* Revenue rose 19% to $188.00 thousand from a year ago; 
analysts expected $325.00 thousand. 
* Vascular Biogenics Ltd's reported EPS for the quarter was a
loss of 12 cents​.
* The mean earnings estimate of analysts had risen by about 2.3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Vascular Biogenics Ltd shares had fallen by 5.9% this
quarter and gained 19.0% so far this year.
* The company reported a quarterly loss of $8.03 million.
* Wall Street's median 12-month price target for Vascular
Biogenics Ltd is $6.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 16 at 12:03 p.m.  ​All
figures in US dollars unless otherwise stated